Epgsocialmediainhealthcareslideshow 110128060558 Phpapp01

SPEAKER: Chris Cooper Managing Director EPG Health Media (founded 1998) 13 years experience in digital healthcare

Research ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object]

Which forms of social media are used most for health related discussion? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

3 stakeholders, 7 SM combinations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Who engages in health-related social media? ,[object Object],[object Object],[object Object],[object Object]

Who are HCPs & patients engaging with via health-related SM today? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Who wants to talk to who via SM? ,[object Object],[object Object],[object Object],[object Object]

Everybody wants to talk to HCPs

2 key discrepancies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Potential to support / influence HCPs through SM? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Potential to support/influence patients through SM? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Obstacles between HCP & Patient SM? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Obstacles between Pharma & customers ,[object Object],[object Object],[object Object],[object Object],[object Object]

Observations so far … ,[object Object],[object Object],[object Object],[object Object],[object Object]

Pharma’s role? ,[object Object],[object Object]

Customers rule ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharma serves ,[object Object],[object Object]

Building trust ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Where is pharma at now? ,[object Object],[object Object],[object Object],[object Object]

Pharma v Agency Who does the SM and who takes the risk? ,[object Object],[object Object],[object Object],[object Object]

All parties are more likely to participate in SM with proper guidelines and regulation ,[object Object]

[object Object],[object Object],[object Object]

Your views ,[object Object],[object Object],[object Object],[object Object],[object Object]

Your views ,[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

Epgsocialmediainhealthcareslideshow 110128060558 Phpapp01

Recommandé

Recommandé

Contenu connexe

En vedette

En vedette (20)

Epgsocialmediainhealthcareslideshow 110128060558 Phpapp01